1[1]Michael A, Meskeowitz, F Michael Cutter. Attacking migraine headachefrom beginning to end[J]. Neurology, 1997,49:1193-1195
2[2]Aunaa SK. Ahmad BK, Welch KMA, et al. Transcranial magneticstimulation confirms hyperexcitability of oecipital cortex in migraine[J]. Neurology, 1998,50:1111-1114
3[3]Bednarczyk EM, Rauler B, et al. Global cerabral blood flow, blood volume and oxygen metabolism in patients with migraine headache [J]. Neurology, 1998,50:1736-1740
4[4]Martin Lanritzen. Pathephysiology of the migraine aura: the spneading epression theory[J]. Brain, 1994,117:199-210
5[5]Peter James Goadsby. Migraine, aura, and cortical spreading depression: why are we still talking about it? [J] Ann Neurol,2001,49:4-6
6[6]Diener HC, Limmroth V. Acute management of migraine triptans andbeyond[J]. Curr Opin Neurol, 1999,12:261-267
7[7]PeterJ. Goadsby, D. Sc., Richard B Lipton, et al. Drug therapy: Migraine-current understanding and treatment[J]. N Engl J Med,2002, 346: 230-245
8[8]Goldstein DJ, Roon KI, Often WW, et al. Selective seratonin IF(5-HF1F)receptor agonist L$334370 for acute migraine: a randomized controlled trial[J]. Lancet,2001,358:1230-1234
9[9]Thansen LL, Olesen J. Nitric oxide theory of migraine [ J]. ClinNenrosci, 1998,49: 28-33
10[10]Stepien A, Chalimoniuk M. Level of nitric oxide-dependent cGMP inpatients with migraine[J]. Cephalalgia, 1998,94:631-634
5Headache classification subcommittee of the international Headache society. The international classification of headache disorders ( second edition) [J]. Cephalalgia, 2004, 24: 9-160.
6Barolin GS. Headache and (concomitant) depression [ J]. Psychopathology, 1986, 19 (suppl 12): s165-s167.
7Danuser H, Bemisk, Thor KB. Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower usinary (?) tract in the anesthetized cat [J]. J Pharmacol Exp Thet, 1995, 274 (2): 820-825.
